Procter & Gamble Company (PG) Financial Statements

Historical financial data — 44 statements covering FY2016–FY2026

Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of more than $87 billion. It operates with a lineup of leading b...

Procter & Gamble Company's revenue increased 3.3% year over year, from $84.28B to $87.03B.

Net income increased 0.5% over the same period, from $15.97B to $16.05B.

Over the 10-year period from FY2016 to FY2026, revenue grew by 33% in total.

Total debt remained relatively stable at $35.02B.

The debt-to-equity ratio stands at 0.64, indicating a moderate leverage profile.

Operating cash flow grew 9.8% to $19.56B.

Procter & Gamble Company maintains a healthy net profit margin of 18.4%.

Recent Financial Statements

Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).

PeriodRevenueNet IncomeGross ProfitEBITOp. Cash FlowTotal AssetsTotal DebtEquity
Q1 FY2025$21.74B+5.9%$3.96B$11.32B$5.80B$4.30B$126.48B$36.15B$52.14B
Q2 FY2025$21.88B+0.7%$4.63B$11.46B$5.74B$4.83B$122.64B$34.69B$51.44B
Q3 FY2025$19.78B-9.6%$3.77B$10.08B$4.56B$3.71B$122.98B$34.14B$52.55B
Q4 FY2025$20.89B+5.6%$3.62B$10.26B$4.36B$4.99B$125.23B$34.51B$52.28B
Q1 FY2026$22.39B+7.2%$4.75B$11.50B$5.86B$5.41B$127.60B$35.95B$53.55B
Q2 FY2026$22.21B-0.8%$4.32B$11.37B$5.37B$4.97B$127.29B$36.64B$53.32B
Q3 FY2026$21.23B-4.4%$3.93B$10.51B$4.58B$4.04B$128.38B$37.03B$54.73B
Q4 FY2026$21.20B-0.1%$3.04B$10.28B$3.95B$5.13B$126.52B$35.02B$54.31B

Balance Sheet Summary (FY2026)

Total Assets
$126.52B
Total Liabilities
$72.21B
Total Equity
$54.31B
Cash & Equivalents
$9.94B
Total Debt
$35.02B
Current Assets
$26.21B
Current Liabilities
$38.69B
Retained Earnings
$135.85B
Current Price: $158.82
Market Cap: $368.9B
Sector: Consumer Defensive

Procter & Gamble Company (PG) Financial Statements & Revenue History

Procter & Gamble Company (PG) is a US-listed stock operating in the Consumer Defensive sector, specifically the Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics industry trading at $158.82 with a market capitalization of $369. This page provides 44 historical financial statements for Procter & Gamble Company, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Procter & Gamble Company reported revenue of $87.0 billion, representing 3.3% year-over-year growth. The net profit margin of 18.4% reflects strong profitability. The debt-to-equity ratio of 0.64 reflects moderate leverage.

PG Income Statement, Balance Sheet & Cash Flow

The financial statements table above shows Procter & Gamble Company's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether PG is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.

  • Revenue trend: Track PG's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
  • Profitability: Net income and gross profit margins reveal how efficiently Procter & Gamble Company converts revenue into earnings.
  • Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of PG's financial position and leverage.
  • Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.

How to Use PG Financial Data

Investors use Procter & Gamble Company's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:

Financial data is sourced from Procter & Gamble Company's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.PG trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.

Related opportunities

Moving today in Consumer Defensive
More Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics stocks
Cheaper alternatives
Similar fundamentals